Cannabis use and the risk of developing a psychotic disorder.
about
Cannabis-induced bipolar disorder with psychotic features: a case reportCannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbancesCannabis use and the course of schizophrenia: 10-year follow-up after first hospitalizationApproach to cannabis use disorder in primary care: focus on youth and other high-risk users.Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendationsSubstance use in people at clinical high-risk for psychosis.Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophreniaCannabinoids and Schizophrenia: Risks and Therapeutic PotentialLinkage analysis followed by association show NRG1 associated with cannabis dependence in African AmericansThe analgesic potential of cannabinoids.Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.Cannabis Epidemiology: A Selective Review.Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders.Critical age windows for neurodevelopmental psychiatric disorders: evidence from animal models.Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives.Downstream effects of endocannabinoid on blood cells: implications for health and disease.Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use.Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia.Perspective: Be clear about the real risks.Age at first tobacco use and risk of subsequent psychosis-related outcomes: A birth cohort study.Association of dopamine receptor D2 TaqI A polymorphism and cannabis use disorder in Lagos, Nigeria.HU210-induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat.Approche en soins primaires pour les problèmes de consommation de cannabis: Plein feu sur les jeunes et autres usagers à risque élevé.From Maps to Multi-dimensional Network Mechanisms of Mental Disorders.The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay.Differential treatment regimen-related effects of HU210 on CB(1) and D(2)-like receptor functionality in the rat basal ganglia.A review of Indian research on co-occurring cannabis use disorders& psychiatric disorders.Adolescent synthetic cannabinoid exposure produces enduring changes in dopamine neuron activity in a rodent model of schizophrenia susceptibility.Marijuana and College Students: A Critical Review of the Literature
P2860
Q24657883-7B509086-D4EA-4FA8-ADBC-23AB8EDF58DDQ28576747-A994B462-FB7A-49C3-B476-E18BD777F6B1Q33579793-3651DE02-056C-48A8-8534-C616688B2591Q34173037-74588B14-346F-4E84-BDF4-9785B0206453Q34453438-093F0F3B-1284-4CF1-B061-0F566060D7E7Q34987780-409DCA90-00C6-449E-94CA-860225E23A17Q34990029-F90C8DE1-12C1-411D-BDC7-85C3BD2E5E89Q35096017-4661CEA7-C8DC-4C51-B73F-F3685C178A3BQ36157669-F9973664-68BB-4E5A-B219-2CED8638A33FQ36975926-CEBCD0F1-06CE-4F3B-B753-22D6742851F4Q37057325-4F3E16C4-5729-4133-A440-AB220AB71185Q37244823-75308FF9-E9E4-4CA8-98D6-5FFDEB5D4194Q37630787-5349A0C5-36CF-46A1-BBAF-C7D59C20E201Q37734568-38894462-F4C3-4A00-ACC5-A319AD612F14Q37770454-F4619801-6EE3-4800-AB7C-3BC875C1C6FFQ37850311-39E4B281-B525-40CC-AA9C-AC268E6AA55AQ37892742-A8EE22FF-6E6B-454D-A12D-336C84C909EEQ38468985-DAA47387-F60D-4312-9B66-08A424BFF124Q38569243-C24BD72C-E454-4CA5-B936-099887E54D19Q38697025-0C8F3033-CDEB-4F2D-B10E-A03E270B08D3Q41329952-4FF9EB9F-C79F-4605-9DDF-EA577A3FE411Q41727467-83BE1DA4-7EA6-4E83-A5FC-431543E37916Q44783858-3D6656F7-7E31-4FE3-A0D3-10B3915ADCB1Q46147054-BE650B5A-5768-4ED0-963A-874BFB23C8A9Q46516634-E2688BDF-F7EC-48C5-8E28-523238A85578Q47200572-36C80A13-670D-4E42-BF9D-540ADD045355Q47895252-6F8C2A1D-38F0-49F8-A582-1D4552EC8497Q48678685-720654A4-47EB-41DE-BA9A-02482482A7A3Q49421334-EA258D52-B0C7-4482-9FDC-07E89A9BB0BDQ50063042-C64822C0-CF2C-49CF-91CF-415B898FE0A9Q58116932-2EB0BF80-A59B-477B-8D3A-92677252B0FB
P2860
Cannabis use and the risk of developing a psychotic disorder.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cannabis use and the risk of developing a psychotic disorder.
@ast
Cannabis use and the risk of developing a psychotic disorder.
@en
type
label
Cannabis use and the risk of developing a psychotic disorder.
@ast
Cannabis use and the risk of developing a psychotic disorder.
@en
prefLabel
Cannabis use and the risk of developing a psychotic disorder.
@ast
Cannabis use and the risk of developing a psychotic disorder.
@en
P2860
P1433
P1476
Cannabis use and the risk of developing a psychotic disorder.
@en
P2093
Wayne Hall
P2860
P356
10.1002/J.2051-5545.2008.TB00158.X
P407
P577
2008-01-01T00:00:00Z